# EDGAR Filing Document

**Accession Number:** 0000742112
**File Stem:** 0001209191-23-013820
**Filing Date:** 2023-2
**Character Count:** 6992
**Document Hash:** b92be2d9364e37de437915a2b4af0fa0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001209191-23-013820.hdr.sgml**: 20230228

**ACCESSION NUMBER**: 0001209191-23-013820

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230220

**FILED AS OF DATE**: 20230228

**DATE AS OF CHANGE**: 20230228

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Purtill Geoffrey
- **CENTRAL INDEX KEY:** 0001896879

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-15103
- **FILM NUMBER:** 23688043

**MAIL ADDRESS:**
- **STREET 1:** ONE INVACARE WAY
- **CITY:** ELYRIA
- **STATE:** OH
- **ZIP:** 44035
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INVACARE CORP
- **CENTRAL INDEX KEY:** 0000742112
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **IRS NUMBER:** 952680965
- **STATE OF INCORPORATION:** OH
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** ONE INVACARE WAY
- **STREET 2:** P O BOX 4028
- **CITY:** ELYRIA
- **STATE:** OH
- **ZIP:** 44036
- **BUSINESS PHONE:** 4403296000

**MAIL ADDRESS:**
- **STREET 1:** ONE INVACARE WAY
- **STREET 2:** P O BOX 4028
- **CITY:** ELYRIA
- **STATE:** OH
- **ZIP:** 44036

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Purtill Geoffrey<br><sub>(Last) (First) (Middle)</sub><br>ONE INVACARE WAY<br><sub>(Street)</sub><br>ELYRIA, OH 44035<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-20 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_President and CEO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>INVACARE CORP [ IVC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Shares | 2023-02-20 |  | D<sup>(1)</sup> |  | 1666 | D | $0.00 | 156086<sup>(2)</sup> | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Employee Stock Option (Right to Buy) | <sup>(3)</sup> |  |  |  |  |  |  | <sup>(4)</sup> | <sup>(4)</sup> | Common Shares | 22611 |  | 22611<sup>(4)(5)</sup> | D |  |

---

### Footnotes:

(1) The reporting person forfeited 1,666 restricted stock units back to the issuer.

(2) Includes 7,439 previously reported restricted stock units issued pursuant to the Invacare Corporation 2018 Equity Compensation Plan.  1,425 of these restricted stock units vest in full on May 15, 2023; 2,680 of these restricted stock units vest in 1/2 increments on May 15, 2023 and May 15, 2024; and 3,334 of these restricted stock units vest equally on November 15, 2023 and November 15, 2024, subject to the reporting person's continued service with the company.

(3) No transaction is being reported on this line.  Reported on previously filed Form 3.

(4) The reporting person holds previously reported options to buy 22,611 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan and the Invacare Corporation 2013 Equity Compensation Plan, granted in reliance upon the exemption provided by Rule 16b-3.  All options were granted between March 18, 2013 and March 16, 2017, at exercise prices between $12.15 and $14.49 per share, will expire between March 18, 2023 and March 16, 2027, and became exercisable between May 15, 2014 and December 31, 2019.

(5) The current balance reflects the expiration of 3,300 options on August 14, 2022.

**Signature:** /s/ Geoffrey Purtill, by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney dated November 24, 2021, on file with the Commission  
**Date:** 2023-02-28

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**